Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity
Objective: Patient-derived xenograft (PDX) models have shown great promise in preclinical and translational applications, but their consistency with primary tumors in phenotypic, genetic, and pharmacodynamic heterogeneity has not been well-studied. This study aimed to establish a PDX repository for...
Main Authors: | Xuanming Chen, Cheng Shen, Zhe Wei, Rui Zhang, Yongsheng Wang, Lili Jiang, Ke Chen, Shuang Qiu, Yuanli Zhang, Ting Zhang, Bin Chen, Yanjun Xu, Qiyi Feng, Jinxing Huang, Zhihui Zhong, Hongxia Li, Guowei Che, Kai Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2021-02-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1779 |
Similar Items
-
Large-scale single-cell transcriptomics of osteosarcoma reveals extensive and different heterogeneity in primary tumors versus murine xenograft model
by: Halvorsen, Stefan
Published: (2016) -
Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy?
by: Eva Hermans, et al.
Published: (2020-01-01) -
Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX)
by: Joan E. Malcolm, et al.
Published: (2019-03-01) -
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
by: Lorena Landuzzi, et al.
Published: (2021-02-01) -
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
by: Feifei Zhang, et al.
Published: (2018-09-01)